Jimmie Mar, DO
Internal Medicine · Glenview
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 9 years
- Touro Un Col of Osteopathic Medicine, Henderson, 2017
Offices
2 locations · Select Outpatient Services Inc · King County Public Hospital District No 2
Looking this up.
Hospitals listed: Evergreenhealth Medical Center · Evergreenhealth Monroe. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Mar’s office at (425) 899-6700 to ask if they take your plan before you enroll.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Evergreenhealth Medical CenterKirkland, WAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of EvergreenHealth, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.335, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Evergreenhealth MonroeMonroe, WAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency departmentPart of EvergreenHealth, which runs 2 hospitalsPatients rate it 2 of 5 · 66% would definitely recommend itOverall rating: 3 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for Evergreenhealth Medical Center
Behind the star rating — Deaths: 3 better, 4 the same, 0 worse of 7 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.335 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.1 (0.11 to 2.09) · 1,003 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.75 (0.44 to 1.07) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 158.5 (106.49 to 210.51) · 62 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 80 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 138 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.2 · 650 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.6 · 512 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.7 · 419 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 3,509 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,473 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.35 (0.16 to 0.54) · 6,368 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.57 (0.58 to 4.56) · 1,401 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.51 (0 to 3.16) · 559 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.37 (0.83 to 3.91) · 1,295 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 5.67 (0 to 12.54) · 573 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.57 (0.84 to 8.31) · 535 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 268 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.99) · 5,577 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.6 · 202 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.642 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.708 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.331 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 197 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 942 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -28.3 · 136 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -0.2 · 719 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 26.7 · 521 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.9 · 708 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.8 (3.1 to 7.7) · 57 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.3 (6.3 to 13.8) · 57 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.7 · 137 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14 (10.5 to 18.7) · 566 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.4) · 1,099 cases | No different | Jan 2024 – Dec 2024 |
What patients said (481 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 88% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 57% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Evergreenhealth Monroe
Behind the star rating — Deaths: 0 better, 3 the same, 0 worse of 3 measures. Safety: 0 better, 1 the same, 0 worse of 1 measures. Readmissions: 0 better, 5 the same, 0 worse of 5 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.04 (0 to 2.13) · 35 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.96 (0.46 to 1.46) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 11.1 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.2 · 57 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.9 · 28 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 429 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.44) · 469 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.05 to 0.48) · 443 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.42 (0.81 to 6.04) · 55 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.31 (0.59 to 4.04) · 52 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.55 (0 to 1.82) · 331 cases | No different | Jul 2022 – Jun 2024 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.6 · 89 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -27 · 47 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -33.6 · 52 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 97 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.6 · 26 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.1 · 42 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (9.5 to 17.7) · 70 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 43 cases | No different | Jan 2024 – Dec 2024 |
What patients said (225 patients answered, 24% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 73% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 65% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 41% |
| "YES", patients would definitely recommend the hospital | 66% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
Year by year
| 2022 | 176 | 565 | 76 | 2.70 | $66,420 | $41,359 |
| 2021 | 325 | 1,042 | 76 | 2.67 | $133,038 | $81,050 |
| 2020 | 131 | 442 | 74 | 2.43 | $52,554 | $34,616 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2022: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 60 | $14,039 | $79 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 73 | $10,384 | $54 |
| Hospital discharge day management, more than 30 minutes | 82 | $6,827 | $81 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $3,381 | $147 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 28 | $3,129 | $104 |
| Follow-up observation care per day, typically 25 minutes | 11 | $918 | $57 |
| Hospital observation care on day of discharge | 14 | $786 | $56 |
2021: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 114 | $28,866 | $79 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 119 | $16,561 | $54 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 80 | $12,807 | $151 |
| Hospital discharge day management, more than 30 minutes | 132 | $11,194 | $81 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 46 | $4,879 | $104 |
| Initial hospital observation care per day, typically 50 minutes | 25 | $2,725 | $109 |
| Hospital observation care on day of discharge | 18 | $1,069 | $59 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 14 | $540 | $28 |
2020: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 48 | $9,162 | $83 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 65 | $8,991 | $57 |
| Hospital discharge day management, more than 30 minutes | 67 | $5,758 | $85 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 31 | $4,970 | $155 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 24 | $2,610 | $109 |
Medicaid work
$627 in 2022
Medicaid paid $627 for 15 billed services this clinician did in 2022, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 15 | $627 |
| 2022 | 15 | 1 | 15 | $627 |
| 2021 | 48 | 2 | 17 | $3,359 |
See the largest Medicaid services in earlier years
2021
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 31 | $1,915 |
| 1ST HOSP IP/OBS HIGH 75 | 17 | $1,445 |
Drugs they prescribed that Part D paid
$49,947
Pharmacies billed $49,947 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 4% of their Part D prescriptions (36 of 895) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%.
815 generic and fewer than 11 brand-name prescriptions · $49,947 in drug cost · 18 antibiotic prescriptions to 14 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Atorvastatin | 100 | $1,300 | $13 |
| Gabapentin | 23 | $607 | $26 |
| Lisinopril | 47 | $575 | $12 |
| Levothyroxine | 29 | $548 | $19 |
| Amlodipine Besylate | 42 | $487 | $12 |
See all 17 drugs
| Atorvastatin | 100 | $1,300 | $13 |
| Gabapentin | 23 | $607 | $26 |
| Lisinopril | 47 | $575 | $12 |
| Levothyroxine | 29 | $548 | $19 |
| Amlodipine Besylate | 42 | $487 | $12 |
| Famotidine | 22 | $450 | $20 |
| Losartan | 39 | $447 | $11 |
| Hydrocodone-Acetaminophen | 25 | $396 | $16 |
| Tamsulosin | 19 | $362 | $19 |
| Atenolol | 22 | $290 | $13 |
| Hydrochlorothiazide | 21 | $231 | $11 |
| Simvastatin | 20 | $229 | $11 |
| Albuterol Sulfate Hfa | 13 | $211 | $16 |
| Trazodone | 16 | $199 | $12 |
| Pantoprazole | 17 | $190 | $11 |
| Metformin | 14 | $148 | $11 |
| Metformin Hcl Er | 12 | $101 | $8 |
Year by year
| 2024 | 895 | 164 | 4% (36) | None | $49,947 |
| 2023 | 1,373 | 208 | 8% (113) | 6% | $85,508 |
| 2022 | 342 | 144 | 5% (17) | None | $28,469 |
| 2021 | 265 | 132 | 6% (15) | 12% | $14,428 |
| 2020 | 156 | 68 | None | 17% | $12,336 |
| 2019 | 100 | 41 | None | 17% | $4,795 |
| 2018 | 111 | 46 | 0% (0) | None | $8,960 |
| 2017 | 45 | 19 | None | None | $3,891 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 33 drugs
| Pradaxa | 11 | $1,548 | $141 |
| Atorvastatin | 113 | $1,530 | $14 |
| Gabapentin | 43 | $893 | $21 |
| Levothyroxine | 36 | $810 | $23 |
| Propranolol | 13 | $760 | $58 |
| Hydrocodone-Acetaminophen | 52 | $728 | $14 |
| Famotidine | 25 | $675 | $27 |
| Lisinopril | 55 | $666 | $12 |
| Losartan | 51 | $620 | $12 |
| Trazodone | 25 | $518 | $21 |
| Amlodipine Besylate | 41 | $464 | $11 |
| Tramadol | 40 | $425 | $11 |
| Diclofenac | 13 | $417 | $32 |
| Tamsulosin | 25 | $417 | $17 |
| Pantoprazole | 31 | $399 | $13 |
| Metformin | 28 | $388 | $14 |
| Atenolol | 25 | $332 | $13 |
| Albuterol Sulfate Hfa | 18 | $289 | $16 |
| Simvastatin | 22 | $252 | $11 |
| Duloxetine | 14 | $226 | $16 |
| Fluticasone Propionate | 17 | $226 | $13 |
| Oxycodone-Acetaminophen | 14 | $219 | $16 |
| Hydrochlorothiazide | 22 | $215 | $10 |
| Tizanidine | 13 | $205 | $16 |
| Quetiapine | 25 | $198 | $8 |
| Triamcinolone Acetonide | 13 | $195 | $15 |
| Omeprazole | 15 | $188 | $13 |
| Ibuprofen | 13 | $180 | $14 |
| Metformin Hcl Er | 21 | $159 | $8 |
| Lisinopril-Hydrochlorothiazide | 13 | $144 | $11 |
| Metoprolol | 15 | $132 | $9 |
| Carvedilol | 12 | $124 | $10 |
| Meloxicam | 15 | $99 | $7 |
2022: 6 drugs
| Cefdinir | 18 | $214 | $12 |
| Quetiapine | 16 | $159 | $10 |
| Amoxicillin-Clavulanate Potass | 18 | $140 | $8 |
| Prednisone | 27 | $126 | $5 |
| Amlodipine Besylate | 16 | $107 | $7 |
| Losartan | 11 | $87 | $8 |
2021: 3 drugs
| Cefdinir | 23 | $326 | $14 |
| Prednisone | 24 | $123 | $5 |
| Amlodipine Besylate | 13 | $43 | $3 |
Money from drug and device companies
$105 in 2022
| 2022 | 3 | 6 | None | $105 |
| 2021 | 5 | 9 | None | $275 |
| 2020 | 2 | 2 | None | $83 |
| 2019 | 2 | 4 | None | $117 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Teflaro | $41 | 2 payments
|
| Novartis Pharmaceuticals | Entresto | $32 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $32 | 2 payments
|
See all 6 published payments
| Novartis Pharmaceuticals | Meals · 2022-08-03 | Entresto | $16 |
| Janssen Pharmaceuticals | Meals · 2022-07-27 | Xarelto | $14 |
| Abbvie | Meals · 2022-07-14 | Teflaro | $20 |
| Novartis Pharmaceuticals | Meals · 2022-06-15 | Entresto | $16 |
| Janssen Pharmaceuticals | Meals · 2022-05-04 | Xarelto | $18 |
| Abbvie | Meals · 2022-04-22 | Teflaro | $21 |
See earlier years (2021, 2020, 2019)
2021: $275
| Edwards Lifesciences | Edwards Sapien 3 Ultra Transcatheter Heart Valve | $104 | 1 payment
|
| Pfizer | Eliquis | $75 | 3 payments
|
| AbbVie | Dalvance | $55 | 3 payments
|
| Vapotherm | Vapotherm | $23 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $19 | 1 payment
|
2020: $83
| Boehringer Ingelheim Pharmaceuticals | Stiolto Respimat | $53 | 1 payment
|
| Si-Bone | Ifuse Implant | $30 | 1 payment
|
2019: $117
| Alexion Pharmaceuticals | Strensiq | $86 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Stiolto Respimat | $31 | 1 payment
|
Professional record
- NPI
- 1649705567
- Licence
- CA 20A20119, NY 305596
- Trained
- Touro Un Col of Osteopathic Medicine, Henderson, 2017 · 9 years ago
- Group
- Select Outpatient Services Inc · King County Public Hospital District No 2
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X); Student in a training program (390200000X)
- Mailing address
- 1721 Technology Dr, San Jose, CA, 95110
- NPI first listed
- 2017-04-28
- NPI last updated
- 2022-09-05
- NPI record certified
- 2022-09-05
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 600 Ivy St, Elmira, NY, 14905 · 830 Washington St, Watertown, NY, 13601
This office lists an electronic records connection.